PDL Biopharma
PDLI
#8400
Rank
โ‚น27.21 B
Marketcap
โ‚น238.28
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Market capitalization of PDL Biopharma (PDLI)

Last known market cap: โ‚น27.21 Billion

As of July 2026 PDL Biopharma has a market cap of โ‚น27.21 Billion. This makes PDL Biopharma the world's 8400th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PDL Biopharma from 2001 to 2021

End of year Market Cap

Year Marketcap Change
2021โ‚น21.00 B1.77%
2020โ‚น20.63 B-28.27%
2019โ‚น28.76 B3.91%
2018โ‚น27.68 B2.52%
2017โ‚น27.00 B13.22%
2016โ‚น23.84 B-38.29%
2015โ‚น38.64 B-51.23%
2014โ‚น79.25 B8.61%
2013โ‚น72.96 B35.39%
2012โ‚น53.89 B17.51%
2011โ‚น45.86 B17.65%
2010โ‚น38.98 B2.47%
2009โ‚น38.04 B7.17%
2008โ‚น35.49 B-56.09%
2007โ‚น80.84 B-21.19%
2006โ‚น102.58 B-28.42%
2005โ‚น143.31 B67.1%
2004โ‚น85.76 B12.09%
2003โ‚น76.51 B110.49%
2002โ‚น36.35 B-74.15%
2001โ‚น140.61 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Eli Lilly
LLY
โ‚น101.116 T 371,403.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น19.068 T 69,958.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น2.95 B-89.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚น22.72 B-16.53%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Nektar Therapeutics
NKTR
โ‚น223.81 B 722.32%๐Ÿ‡บ๐Ÿ‡ธ USA